Approval · Notice of Compliance 302 · 2004
ACTIVELLE: Notice of Compliance 302
Issued March 30, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 302
- Date
- March 30, 2004
- Company
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Hormone replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTIVELLE | 02249405 | Marketed |
Medicinal ingredients
- ESTRADIOL 1 MG per TAB
- NORETHINDRONE ACETATE 0.5 MG per TAB